Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Roadzen Posts First ‘Rule of 40’ Quarter in Two Years; FY2026 Net Loss Narrows 69% and Adjusted EBITDA Loss Improves 58%, with Seventh Straight Quarter of Adjusted EBITDA Gains Nearing Breakeven ...
-
LOS ANGELES, June 29, 2026 (GLOBE NEWSWIRE) -- XMax Inc. (NASDAQ: XMAX; “XMax” or the “Company”), an artificial intelligence infrastructure provider and a distributor of contemporary-styled...
-
MUSIC CIRCUS TO DRIVE TRYHARD HOLDINGS’ EXPANSION IN CULTURAL PROGRAMMING AND NATIONWIDE EVENTS WITH SBI HOLDINGS
-
WOBURN, Mass., June 29, 2026 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (Nasdaq: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today...
-
HOUSTON, TX, June 29, 2026 (GLOBE NEWSWIRE) -- Abundia Global Impact Group, Inc. (NYSE American: AGIG) (“Abundia” or the “Company”), a low-carbon energy solutions company focused on converting...
-
PARIS, June 29, 2026 (GLOBE NEWSWIRE) -- Pasqal, a global leader in neutral-atom quantum computing, today announced the appointment of Stéphane Rougeot as Chief Financial Officer (CFO). Rougeot — a...
-
Mdxhealth Announces Peer-Reviewed Publication of Oxford GPS-ProMPT Study in European Urology Oncology, Establishing Scientific Foundation for the Landmark GPS-ProtecT Randomized Controlled Trial ...
-
Vancouver, Canada, June 29, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on the discovery and development...
-
Latin Metals reports surface samples up to 63.88 g/t gold and 175.34 g/t silver at La Flora, advancing a high-grade target toward initial drilling.
-
Preferred AI tenant selected based on commercial terms, financial strength, credit quality, and operational alignment with the long-duration lease structure Further announcement with counterparty...